Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04382391 · ClinicalTrials.gov registry record · NA
Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms
A NA study, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT04382391 is a NA study that was terminated before completion, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 21 participants.
The verdict
NCT04382391, a NA study, was terminated before completion, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The study is a prospective, randomized, controlled investigation designed for comparison of two groups for the reduction of respiratory distress in a CoViD-19 population, using gammaCore Sapphire (nVNS) plus standard of care (active) vs. standard of care alone (SoC), the control group. The gammaCore® (nVNS) treatments will be used acutely and prophylactically. The aims of this study are to summarize and compare the incidence of clinical events and pro-inflammatory cytokine levels in patients randomized to use of gammaCore Sapphire plus standard of care vs standard of care alone in patients hospitalized for CoViD-19. Secondary objectives are demonstrate the safety of gammaCore Sapphire use in patients hospitalized for CoViD-19.
Interventions
- DEVICE gammaCore® Sapphire (non-invasive vagus nerve stimulator)
- OTHER Standard of care therapies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2020-05-15 |
| Est. Completion | 2023-04-13 |
| Phase | NA |
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)34 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04382391
The ClinicalTrials.gov registry entry for NCT04382391 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which gammaCore® Sapphire (non-invasive vagus nerve stimulator) is the first listed.
NCT04382391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04382391 about?
NCT04382391 is a clinical study titled "Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms". The study is a prospective, randomized, controlled investigation designed for comparison of two groups for the reduction of respiratory distress in a CoViD-19 population, using gammaCore Sapphire (nVNS) plus standard of care (active) vs. standard of care alone (SoC), the control group. The gammaCore...
What is the current status of trial NCT04382391?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2020-05-15. Estimated completion is 2023-04-13.
What interventions are being tested in trial NCT04382391?
The interventions under investigation include: gammaCore® Sapphire (non-invasive vagus nerve stimulator) (DEVICE), Standard of care therapies (OTHER).
Who is sponsoring clinical trial NCT04382391?
This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.